Neudle.com: multiple sclerosis early treatment

Differential
(Click to cross reference)

abscess, intracerebral

acute disseminated encephalomyelitis

adverse drug reaction

Alzheimer's disease

Alzheimer's disease, diagnosis of

Alzheimer's disease, preclinical

amyloid beta protein

amyloid imaging

amyloid plaques

angiitis, isolated of CNS

anti MAG antibodies

antibodies to myelin basic protein

antimyelin antibodies

Barkhof MR criteria for MS

brainstem, infarction of

brainstem, lesion of

carcinoma

carcinoma of breast

carotid artery occlusion, intracranial

CAT scan

CAT scan, abnormal

CAT scan, cerebrovascular disease

CAT scan, dense artery sign

CAT scan, early changes in CVA

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, mass effect on

CAT scan, ring sign

central nervous system, infection of

cerebellar infarction

cerebellar lesion

cerebral arteries

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, protein of

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, prognosis in

cerebrovascular accident, recurrent

cerebrovascular accident, severity

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, volume

cerebrovascular accident, work up for

cerebrovascular accident, young adult

children

Clinical Pathologic Conference(C.P.C.)

cognition

complications

controversies in neurology

cop 1

corneal dystrophy

corpus callosum

corpus callosum, lesion of

cyclophosphamide

degenerative diseases of CNS

dementia

dementia, diagnostic evaluation of

dementia, early detection

dementia, presenile

dementia, rapidly progressive

dementia, screening for

demyelinating disease

diabetes insipidus

diagnostic criteria

differential diagnosis

disability rating scale, neurological

disability, neurological

disease modifying agents

efficacy

encephalitis

encephalitis, viral

encephalomyelitis, postinfectious

encephalopathy, Hashimoto's

encephalopathy, metabolic

fibrinolytic agents, complications

fingolimod

florbetapir

flu-like illness

fourth ventricle, shift of

fumarate

gadolinium

gait disorder

gammaglobulin therapy, intravenous

genetic neurologic disorders

head injury

hearing loss

hearing loss, sudden, unilateral

hemiparesis

heralding manifestation

herpes simplex encephalitis

herpes virus

herpes virus infection

hippocampal atrophy

hippocampus

hydrocephalus

hydrocephalus, exvacuo

hypertension

immunomodulation

immunosuppressive agents

internal carotid artery

intracerebral hemorrhage

intravenous

ischemic penumbra

Jakob-Creutzfeldt disease

liver function enzymes

lobar atrophy

Marburg's disease

McDonald criteria for MS

medulla oblongata, infarction of

memory, impairment of

mild cognitive impairment

misdiagnosis

mitoxantrone

monoclonal antibodies

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, fast

MRI, field strength

MRI, field strength, high

MRI, functional

MRI, incidental finding

multiple sclerosis, acute

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, early onset

multiple sclerosis, etiology of

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, MRI conversion

multiple sclerosis, MRI criteria

multiple sclerosis, pathogenesis

multiple sclerosis, preclinical

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, secondary progressive

multiple sclerosis, spinal form

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

N-acetyl-L-aspartic acid

natalizumab

neoplasm, intracranial

neoplasm, primary intracerebral

neoplasm, primary intracranial

neoplasm, primary of CNS

neoplasm, primary of CNS-children

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neuropathology

neuroprotective agents

old age, neurology of

optic nerve, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optical coherence tomography

Parkinson disease

Parkinson disease, late onset

Parkinson disease, treatment of

Parkinson disease, young onset

periventricular leukomalacia

Pittsburgh Compound B

placebo

pons, infarction of

posterior cerebral artery territory infarction

posterior fossa

posterior fossa, lesion of

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

prion disease

prognosis

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

pseudotumor

rapidly progressing neurologic illness

remote effect of cancer on the nervous system

revascularization, surgical

sensorineural hearing loss

serologic testing

single photon emission computed tomography

slurred speech

somnambulism

spinal cord

spinal cord, enlargement

spinal cord, intramedullary cyst of

spinal cord, lesion of

spinal cord, neoplasm

spinal cord, neoplasm, infants and children

steroid

steroid therapy, CNS treatment and complications with

stroke disability scale

symmetric brain lesions

symptomatic

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

T lesion of MCA-ICA

temporal lobe, atrophy

thyroiditis

tinnitus

tissue plasminogen activator, intravenous

toxic encephalopathy

transient ischemic attack

treatment of neurologic disorder

uremia

urinary incontinence

urinary retention

ventricular enlargement

vertebral-basilar insufficiency

viral infection, reactivation

visual evoked response

West Nile fever

white matter disease

white matter disease, periventricular

Showing articles 950 to 1000 of 4362 << Previous Next >>

Medial Temporal Lobe Volumetrics in Traumatic Brain Injury
AJNR 18:25-28, Jack,C.R.,et al, 1997

Multiple Sclerosis Presenting as Transverse Myelopathy:Clinical and MRI Features
Neurol 48:65-73, Simnad,V.I.,et al, 1997

Cavernous Angioma of the Brain Stem Mimicking Multiple Sclerosis
NEJM 336:875-876, Vrethem,M.,et al, 1997

A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997

Offspring Recurrence Rates and Clinical Characteristics of Conjugal Multiple Sclerosis
Lancet 349:1587-1590, Robertson,N.P.,et al, 1997

Amelioration of Refractory Dysesthetic Limb Pain in Multiple Sclerosis by Gabapentin
Neurol 49:304-305, Samkoff,L.M.,et al, 1997

Doctors & Pts Don't Agree:Cross Sectional Study of Pts' & Doctors'Perceptions & Assessments of Disability in MS
BMJ 314:1580-1583, Rothwell,P.M.,et al, 1997

The Impact of Inpatient Rehabilitation on Progressive Multiple Sclerosis
Ann Neurol 42:236-244, Freeman,J.A.,et al, 1997

Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997

Character of MRI Response to Trtm with Interferon Beta-1B:Enhancing MRI Lesion Freq as Prim Outcome Measure
Neurol 49:862-869, Stone,L.A.,et al, 1997

Impact of Interferon Beta-1A On Neurologic Disability in Relapsing Multiple Sclerosis
Neurol 49:358-363, Rudick,R.A.,et al, 1997

Quantitative Assessment of Sustained-Release 4-Aminopyridine for Symptomatic Treatment of Multiple Sclerosis
Neurol 48:817-821, Schwid,S.R.,et al, 1997

Glatiramer Acetate for Relapsing Multiple Sclerosis
The Medical Letter 39:61-62, , 1997

Serum Angiotensin-Converting Enzyme in Multiple Sclerosis
Arch Neurol 54:1012-1015, Constantinescu,C.S.,et al, 1997

Hemiageusia:An Unusual Presentation of Multiple Sclerosis
JNNP 54:657, Pascual-Leone,A.,et al, 1997

Serial Neuropsychological Assess & Magnetic Resonance Imagingf Analysis in Multiple Sclerosis
Arch Neurol 54:1018-1025, Hohol,M.J.,et al, 1997

Randomised Trial of Oral and Intravenous Methylprednisolone in Acute Relapses of Multiple Sclerosis
Lancet 349:902-906, 8931997., Barnes,D.,et al, 1997

Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997

Paramedian Pontine Infarction
Stroke 28:809-815, Kataoka,S.,et al, 1997

Olfactory Dysfunction in Multiple Sclerosis
(Letter) NEJM 336:1918-1919997., Doty,R.L.,et al, 1997

Assessment of Olfaction in Multiple Sclerosis:Evidence of Dysfunction by Olfactory Evoked Response and Identification Tests
JNNP 63:145-151, Hawkes,C.H.,et al, 1997

Epstein-Barr Virus Encephalomyelitis Diagnosed by Polymerase Chain Reaction:Detection of the Genome in the CSF
Neurol 48:1351-1355, Tselis,A.,et al, 1997

Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997

Unusual Causes of Headache
Neurol 48:1494-1499, Ramadan,N.M., 1997

Lymphoproliferative Disorders and Motor Neuron Disease:An Update
Neurol 48:1671-1678, Gordon,P.H.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Quality of Life Among Persons with Multiple Sclerosis and Their Caregivers
Neurol 48:74-80, Aronson,K.J., 1997

Randomised Placebo-Controlled Trial of Monthly IVIg Therapy in Relapsing-Remitting MS
Lancet 349:589-593, 5861997., Fazekas,F.,et al, 1997

A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial of Influenza Immunizaation in MS
Neurol 48:312-314, Miller,A.E.,et al, 1997

HLA Typing in Acute Optic Neuritis, Relation to MS & Magnetic Resonance Imaging Findings
Arch Neurol 54:76-80, Frederiksen,J.L.,et al, 1997

Correlation of Clinical, Magnetic Resonance Imaging, and Cerebrospinal Fluid Findings in Optic Neuritis
Ann Neurol 41:392-398, Jacobs,L.D.,et al, 1997

Adult-Onset Subacute Sclerosing Panecephalitis:Case Reports and Review of the Literature
Mov Dis 12:342-353, Singer,C.,et al, 1997

Motor Neuron Disease, Lymphoproliferative Disease, and Bone Marrow Biopsy
Muscle & Nerve 19:1334-1337996., Louis,E.D.,et al, 1996

Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996

Increased Writing Activity in Neurological Conditions:A Review and Clinical Study
JNNP 61:510-514, vanVugt,P.,et al, 1996

Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996

Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996

Age on Onset, Sex, & Cardiomyopathy as Predictors of Disability and Survival in Friedreich's Disease
Neurol 47:1260-1264, DeMichele,G.,et al, 1996

Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996

Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996

Hypothermia in Multiple Sclerosis
JNNP 61:369-375, White,K.D.,et al, 1996

Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996

Clinicopath Conf
Distinguishing Acute Disseminated Encephalomyelitis from Multiple Sclerosis, BMJ 313:802-8041996., , 1996

Treatment of Refractory Urge Urinary Incontinence with Sacral Spinal Nerve Stimulation in Multiple Sclerosis Patients
Lancet 348:717-719, Bosch,J.L.&Broen,J., 1996

Diagnosing Motor Neurone Disease
BMJ 312:650-651, Chancellor,A.M., 1996

Twelfth-Nerve Palsy:Analysis of 100 Cases
Arch Neurol 53:561-566, Keane,J.R., 1996

Subacute Leukoencephalitis Caused by CNS Infection with Human Herpesvirus-6 Manifesting as Acute Multiple Sclerosis
Neurol 47:145-148, Carrigan,D.R.,et al, 1996

Prospective Evaluation of MRI Lumbosacral Nerve Root Enhancement in Acute Guillain-Barre Syndrome
Neurol 47:813-817, Gorson,K.C.,et al, 1996

Triple Dose of Gadolinium-DPTA and Delayed MRI in Patients with Benign Multiple Sclerosis
JNNP 60:526-530, Filippi,M.,et al, 1996

Idiopathic Transverse Myelitis:MR Characteristics
AJNR 17:1151-1160, Choi,K.H.,et al, 1996

Showing articles 950 to 1000 of 4362 << Previous Next >>